Takeda Pharmaceutical Company Limited
LYOPHILIZED RECOMBINANT VWF FORMULATIONS
Last updated:
Abstract:
The present invention provides long-term stable pharmaceutical formulations of lyophilized recombinant von-Willebrand Factor (rVWF) and methods for making and administering said formulations.
Status:
Application
Type:
Utility
Filling date:
29 Oct 2021
Issue date:
18 Aug 2022